1. Home
  2. GILT vs UPB Comparison

GILT vs UPB Comparison

Compare GILT & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • UPB
  • Stock Information
  • Founded
  • GILT 1987
  • UPB 2021
  • Country
  • GILT Israel
  • UPB United States
  • Employees
  • GILT N/A
  • UPB N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • UPB
  • Sector
  • GILT Technology
  • UPB
  • Exchange
  • GILT Nasdaq
  • UPB NYSE
  • Market Cap
  • GILT 399.1M
  • UPB 457.2M
  • IPO Year
  • GILT 1993
  • UPB 2024
  • Fundamental
  • Price
  • GILT $7.56
  • UPB $7.98
  • Analyst Decision
  • GILT Strong Buy
  • UPB Strong Buy
  • Analyst Count
  • GILT 2
  • UPB 4
  • Target Price
  • GILT $8.50
  • UPB $56.50
  • AVG Volume (30 Days)
  • GILT 541.7K
  • UPB 245.5K
  • Earning Date
  • GILT 02-12-2025
  • UPB 03-04-2025
  • Dividend Yield
  • GILT N/A
  • UPB N/A
  • EPS Growth
  • GILT 6.30
  • UPB N/A
  • EPS
  • GILT 0.44
  • UPB N/A
  • Revenue
  • GILT $305,448,000.00
  • UPB $2,207,000.00
  • Revenue This Year
  • GILT $47.31
  • UPB N/A
  • Revenue Next Year
  • GILT $10.31
  • UPB N/A
  • P/E Ratio
  • GILT $17.35
  • UPB N/A
  • Revenue Growth
  • GILT 14.79
  • UPB 82.10
  • 52 Week Low
  • GILT $4.04
  • UPB $6.65
  • 52 Week High
  • GILT $8.05
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • GILT 59.86
  • UPB N/A
  • Support Level
  • GILT $6.73
  • UPB N/A
  • Resistance Level
  • GILT $8.05
  • UPB N/A
  • Average True Range (ATR)
  • GILT 0.37
  • UPB 0.00
  • MACD
  • GILT 0.00
  • UPB 0.00
  • Stochastic Oscillator
  • GILT 62.88
  • UPB 0.00

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.

Share on Social Networks: